Winthrop P. Rockefeller Cancer Institute
September 3, 2020
UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects
LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…
September 2, 2020
UAMS Lung Cancer Researcher Contributes to Publication of Validation Protocols for Liquid Biopsy to Detect Cancer
Donald J. Johann, M.D., a lung cancer researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), played an integral role in the publication of research related to liquid biopsy tests, or blood tests, for cancer.
September 1, 2020
UAMS’ Alan Tackett, Ph.D., Named to NIH Mechanisms of Cancer Therapeutics Study Section
Alan Tackett, Ph.D., was recently named a member of the National Institutes of Health (NIH) Mechanisms of Cancer Therapeutics-1 (MCT1) Study Section, one of the major review boards for evaluation of cancer research by the NIH Center for Scientific Review.
August 28, 2020
Frits van Rhee, M.D., Ph.D., Named Cancer Institute Auxiliary Distinguished Honoree
From the safety and comfort of their homes, 46 guests gathered at their computers Aug. 21 to recognize one of the UAMS Winthrop P. Rockefeller Cancer Institute’s highly respected physicians: Frits van Rhee, M.D., Ph.D. At the virtual reception, van Rhee was presented with the Distinguished Honoree Award, a presentation made annually by the Cancer…
August 26, 2020
$10.6 Million Federal Grant to Expand National Proteomics Resource at UAMS
A $10.6 million grant from the National Institutes of Health (NIH) will allow the University of Arkansas for Medical Sciences (UAMS) to greatly expand its proteomics resource. This grant will establish the IDeA National Resource for Quantitative Proteomics as the first NIH National Resource in Arkansas, which will serve biomedical researchers across the entire nation.
August 24, 2020
UAMS Researchers See 43% Funding Increase in FY2020
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 43% this past year, with $158.1 million in grants by the end of the fiscal year, June 30. The bulk of the funding is from the National Institutes of Health (NIH) and other federal…
August 5, 2020
$780,000 Federal Grant Will Give UAMS Medical Students Hands-on Cancer Research Experience
LITTLE ROCK — A $780,000 grant from the National Cancer Institute will fund a hands-on summer cancer research experience for medical students at the University of Arkansas for Medical Sciences (UAMS). “Partnership in Cancer Research will provide focused and innovative research experiences in laboratories, community outreach programs and clinics for selected first- and second-year students…
August 4, 2020
Early Melanoma Diagnosis Leads to Positive Outcome for Young Mom
Achieving the perfect tan is a summertime goal for many young women. But for fair-skinned Kristi Dannelley, getting a golden glow was no easy task. That’s why she turned to tanning beds. “I spent hours in tanning beds as a teenager and in my early 20s,” said Dannelley, president of Magna IV in Little Rock….
July 29, 2020
UAMS Radiation Oncology Residency Program Receives Accreditation
The Radiation Oncology Residency program at the University of Arkansas for Medical Sciences (UAMS) has received accreditation from the Accreditation Council for Graduate Medical Education, which reviews all programs annually. When efforts to launch the program began in 2017, there was no residency training for radiation oncology in the state, and Arkansas was one of…
July 24, 2020
Grant Gives UAMS Physician-Scientist Access to Gene Analysis Software
New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.
Previous page Next page